Plain-English translation of NCT06006169 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two experimental medications called and to see if they can help treat head and neck cancer that has come back or spread to other parts of the body. You would receive one of the medications alone, or both medications together. The study will measure how well the treatment works and what side effects occur.
Currently, people with recurrent or metastatic head and neck cancer have limited treatment options, especially if previous therapies didn't work or caused too many side effects. This trial aims to see if these new medications offer a better choice for patients who need help.
You likely qualify if…
You likely don't qualify if…
You would receive the medication as a treatment cycle lasting 3 weeks. If the treatment appears to be helping and you tolerate it well, you may continue receiving additional cycles. The study team will monitor you with blood tests and imaging scans to assess whether the cancer is responding and to watch for side effects. Treatment stops if your disease worsens, you experience unacceptable side effects, or for other reasons decided with your doctor.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China